The management of the private homeopathic pharmacies on Mosfilmovskaya street brought to administrative responsibility for gross violations of licensing requirements for pharmaceutical activity. As reported on the website of Roszdravnadzor in Moscow and Moscow region, the pharmacy sold medicine that was supposed to help patients to avoid infection with coronavirus.
“Discovered the drugs, made of pharmaceutical substances of unknown origin, as well as a vial of unknown liquid and dead reptiles. According to the explanations of the pharmacy staff, the use of manufactured drugs eliminates the possibility of infection of a patient by a coronavirus. The pharmacy also stated that an unknown fluid from the vessel with the dead reptiles it is recommended to take children to treat any diseases”, – stated in the message.
Drugs arrested, the issue of bringing the company to administrative responsibility for illegal manufacture of drugs and illegal circulation of precursors, and also for rough violation of license requirements to pharmaceutical activity. According to the Agency “Moscow”, the employee of the pharmacy has destroyed the liquid from the vessel with reptiles and tried to escape with a bottle of dead snakes that inspectors are unable to conduct the examination.
Pharmacy in Moscow produced a “cure” from the dead reptile, which “excludes infection with coronavirus”.
According to the Agency “Moscow”, Roszdravnadzor found the illegal production during test purchases in private homeopathic pharmacy in Mosfilmovskaya street.
“Discovered the drugs, made of pharmaceutical substances of unknown origin, as well as a vial of unknown liquid and dead reptiles. According to the explanations of the pharmacy staff, the use of manufactured drugs eliminates the possibility of infection of the patient with coronavirus”.
The liquid from the vessel with reptiles was designed to treat children from “any illness”, said the pharmacy. The employee destroyed the liquid and tried to escape with a bottle of dead snakes that inspectors are unable to conduct the examination.
The Ministry initiated administrative proceedings.
In Europe for the treatment of coronavirus will use the antiviral drug ramdevpir. A study conducted in 10 countries involving more than a thousand patients, showed that ramdevpir administered to patients intravenously, accelerated the healing process of hospitalized. On average, the drug reduces hospitalization of patients from 15 to 11 days.
In the United States in early may issued a permit for the use of ramdevpir in hospitals to treat patients with the coronavirus, then the use of the drug approved in Japan and South Korea. Meanwhile, the drug can become almost the exclusive property of the United States. According to the statement on the website of the Ministry of health of the country in July to go 100% supply of the pharmaceutical company Gilead, and in August and September – 90%. In conditions similar buying drug availability in European hospitals may be limited.
Speaking about the availability of the drug in the Russian Federation, Director General of the Association of Russian pharmaceutical manufacturers Viktor Dmitriev said that the analogues of ramdevpir in Russia no, but there are other treatments and other anti-viral drugs that act on RNA viruses. Director of the Institute of health Economics HSE Larisa Popovich stated that the weakening of the virus Russian doctors used primarily favipiravir and a combination of lopinavir and ritonavir. Therefore, the problem of the availability of ramdevpir in this case can be considered irrelevant.
Read more: https://www.newsru.com/russia/06aug2020/reptile_corona.html